目的评价国产普卢利沙星治疗轻、中度急性细菌感染的临床疗效与安全性。
Objective To evaluate the clinical efficacy and safety of prulifloxacin for the treatment of slight and moderate acute bacterial infections.
他说，在受试的感染人群中，服用普卢利沙星的人中有71%在48小时内痊愈了，而安慰剂组仅有33%。
In those who could be tested for infection, 71 percent were well within 48 hours after getting prulifloxacin, compared to 33 percent of those given a placebo pill, he said.
目的：改进普卢利沙星的生产工艺。
OBJECTIVE: To improve the production technology of prulifloxacin.
目的：筛选普卢利沙星胶囊的最佳处方组成。
Objective: To optimize the best formulation technique of Prulifloxacin capsule.
结论国产普卢利沙星注射液治疗轻、中度细菌感染疗效确切，安全性好。
Conclusions Prulifloxacin is as effective and safe as levofloxacin in the treatment of slight and moderate acute bacterial infections.
目的：建立普卢利沙星有关物质检查的HPLC法。
Objective: To establish a method for the test of impurities in prulifloxacin by HPLC.
目的建立人血浆中普卢利沙星活性代谢产物NM394的高效液相色谱测定方法。
OBJECTIVE To establish a method to determine NM394 concentration in the plasma by HPLC.
目的建立人血浆中普卢利沙星活性代谢产物NM394的高效液相色谱测定方法。
OBJECTIVE To establish a method to determine NM394 concentration in the plasma by HPLC.
应用推荐